|
🐜
|
Selective inhibition of BET bromodomains
25 auth.
P. Filippakopoulos,
J. Qi,
S. Picaud,
Yao Shen,
William B. Smith,
O. Fedorov,
Elizabeth M. Morse,
T. Keates,
T. Hickman,
I. Felletár,
M. Philpott,
S. Munro,
M. Mckeown,
Yuchuan Wang,
A. Christie,
...
N. West,
M. J. Cameron,
Brian E. Schwartz,
T. Heightman,
N. L. La Thangue,
C. French,
O. Wiest,
A. Kung,
S. Knapp,
J. Bradner
|
11 |
2010 |
11
🐜
|
|
🐜
|
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
20 auth.
J. Bradner,
Raymond H. Mak,
S. Tanguturi,
Ralph Mazitschek,
S. Haggarty,
K. Ross,
Cindy Y. Chang,
Jocelyn Bosco,
N. West,
Elizabeth M. Morse,
...
Katherine I. Lin,
J. Shen,
Nicholas Kwiatkowski,
N. Gheldof,
J. Dekker,
D. DeAngelo,
S. Carr,
S. Schreiber,
T. Golub,
B. Ebert
|
7 |
2010 |
7
🐜
|
|
🦁
|
Integrin Cytoplasmic Tail Interactions
Elizabeth M. Morse,
Nina N. Brahme,
D. Calderwood
|
7 |
2014 |
7
🦁
|
|
🐜
|
Defining the role of syndecan-4 in mechanotransduction using surface-modification approaches
14 auth.
R. Bellin,
James D. Kubicek,
Matthew J. Frigault,
Andrew J. Kamien,
R. Steward,
Hillary M Barnes,
Michael B. DiGiacomo,
Luke J. Duncan,
Christina K. Edgerly,
Elizabeth M. Morse,
...
C. Park,
J. Fredberg,
Chao-Min Cheng,
P. Leduc
|
6 |
2009 |
6
🐜
|
|
🐬
|
Signaling, Regulation, and Specificity of the Type II p21-activated Kinases*
B. Ha,
Elizabeth M. Morse,
B. Turk,
T. Boggon
|
5 |
2015 |
5
🐬
|
|
🦁
|
PAK6 targets to cell–cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape
Elizabeth M. Morse,
Xiaowen Sun,
Jordan Olberding,
B. Ha,
T. Boggon,
D. Calderwood
|
4 |
2016 |
4
🦁
|
|
🐜
|
Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6
8 auth.
Jia Gao,
B. Ha,
H. Lou,
Elizabeth M. Morse,
Rong Zhang,
D. Calderwood,
...
B. Turk,
T. Boggon
|
4 |
2013 |
4
🐜
|
|
🐜
|
A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold.
10 auth.
M. Kemp,
Qiu Wang,
J. H. Fuller,
N. West,
Nicole M. Martinez,
Elizabeth M. Morse,
...
M. Weïwer,
S. Schreiber,
J. Bradner,
A. Koehler
|
4 |
2011 |
4
🐜
|
|
🐜
|
Zasp regulates integrin activation
9 auth.
M. Bouaouina,
Klodiana Jani,
J. Long,
Stefan M. Czerniecki,
Elizabeth M. Morse,
Stephanie J. Ellis,
...
Guy Tanentzapf,
F. Schöck,
D. Calderwood
|
4 |
2012 |
4
🐜
|
|
🐬
|
Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4)
B. Ha,
Sezin Yigit,
N. Natarajan,
Elizabeth M. Morse,
D. Calderwood,
T. Boggon
|
0 |
2022 |
0
🐬
|
|
🐜
|
Small-molecule bromodomain inhibitors for cancer therapy
14 auth.
J. Qi,
P. Filippakopoulos,
S. Picaud,
William B. Smith,
T. Keates,
Elizabeth M. Morse,
M. Philpott,
K. Shaw,
O. Fedorov,
N. West,
...
T. Heightman,
C. French,
S. Knapp,
J. Bradner
|
0 |
2010 |
0
🐜
|
|
🐬
|
Author Correction: Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4)
B. Ha,
Sezin Yigit,
N. Natarajan,
Elizabeth M. Morse,
D. Calderwood,
T. Boggon
|
0 |
2023 |
0
🐬
|
